Clinical Trials · NCT01620463
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 32
- Start date
- Dec 2002
- Locations
- 1 site, Japan
- Primary endpoint
- Body weight